We recently updated our Privacy Notice and Terms of Use.
Journal Supplement Journal Supplement

Diagnosing and Managing Schizophrenia: Practical Strategies for the Federal Healthcare Professional

Time to Complete:
60 Minutes

Maximum Credits:


Journal Supplement Journal Supplement
Time to Complete:
60 Minutes



Maximum Credits:
Share on:
Journal Supplement Journal Supplement

Share on:

Time to Complete:
60 Minutes

Maximum Credits:

Overview: This activity addresses important issues in the identification, diagnosis, and management of schizophrenia in patients within the federal healthcare system, which includes active-duty servicemembers, Veterans, and others. It is designed to increase the awareness of schizophrenia as a possible diagnosis among other common conditions in this patient population, assist with the development of treatment plans based on current guideline recommendations, and guide the modification of treatment regimens based on patient response, adverse effects, adherence concerns, and other treatment challenges.

CME Information:

Learning Objectives
Upon completion, participants should be able to:

  • Identify the principle clinical manifestations of schizophrenia and schizoaffective disorder
  • Describe specific issues related to the management of schizophrenia and schizoaffective disorder that are unique to active-duty servicemembers and Veterans receiving treatment within federal healthcare systems
  • Develop individualized, evidence-based assessment and treatment strategies that integrate pharmacologic and psychosocial treatment for individuals with schizophrenia or schizoaffective disorder
  • Apply management strategies and monitoring plans for addressing therapeutic response and adverse effects of psychopharmacologic interventions

Activity Chair/Advisor
Mark Olfson, MD, MPH
Professor of Clinical Psychiatry
College of Physicians and Surgeons of Columbia University
Research Psychiatrist II
New York State Psychiatric Institute
New York, NY

Activity Advisors
William V. Bobo, MD, MPH
Assistant Professor of Psychiatry
Vanderbilt University School of Medicine
Nashville, TN

Robert A. Rosenheck, MD
Professor of Psychiatry and Public Health
Director, Division of Mental Health Services and Outcomes Research
Department of Psychiatry
Yale School of Medicine
New Haven, CT

Katherine Kahn
Huntington, MA

Activity Planners
Rachel A. Karcher, PharmD
Director of Clinical Content
Baltimore, MD

Lisa R. Rinehart, MS, ELS
Senior Managing Editor
Baltimore, MD

Target Audience
The primary audience for this activity includes physicians, clinical pharmacists, nurse practitioners, physician assistants, psychologists, and nurses who manage the health of beneficiaries in the federal healthcare system, including those in the VA and military (through all branches of service in DOD).

Series Overview/Statement of Need
Current data suggest that schizophrenia is under diagnosed in the United States military as a result of a variety of factors, including a focus on diagnosing other conditions and the stigma associated with seeking mental health services. In addition, these sources have demonstrated that, when diagnosed, servicemembers and others in the VA healthcare system do not always receive evidence-based care, nor do they always receive the support they need to manage medication side effects and adhere to therapies. Educational interventions are needed to help military healthcare professionals become more confident and competent in assessing and identifying schizophrenia and in implementing safe and effective treatment regimens early to reduce symptoms and improve long-term outcomes. Clinicians would also benefit from receiving strategies that can help them ensure that their patients are adhering to therapies and managing medication side effects.

Accreditation/Designation Statements
The College of Physicians and Surgeons of Columbia University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The College of Physicians and Surgeons designates this educational activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Med-IQ is accredited by the California Board of Registered Nursing to provide continuing education to nurses.

Provider approved by the California Board of Registered Nursing, provider number CEP 14745, for 1.0 contact hour.

ACPEMed-IQ is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

1.0 contact hour (0.10 CEU) of credit for pharmacists. ACPE #0476-9999-11-006-H06-P. This knowledge-based activity is designed for all pharmacists.

Statement of Participation
Nurse practitioners, physician assistants, and other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.

Medium and Method of Participation
This complimentary CME/CE activity consists of a 1.0-credit publication. To receive credit, each participant must read the introductory CME material, read the publication, and complete the post-test (answering at least 70% of the questions correctly), attestation, and evaluation.

Original Release Date: May 26, 2011
Expiration Date: May 25, 2012
Estimated Time to Complete This Activity: 1.0 hour

Disclosure Policy
The College of Physicians and Surgeons and Med-IQ require any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. The College of Physicians and Surgeons and Med-IQ have policies in place that will identify and resolve COIs prior to this educational activity. The College of Physicians and Surgeons and Med-IQ also require faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.

Disclosure Statement
The content of this publication has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to provide unbiased content.

Mark Olfson, MD, MPH has indicated no real or apparent conflicts.

William V. Bobo, MD has indicated no real or apparent conflicts.

Robert A. Rosenheck, MD
Consulting fees/advisory boards: Otsuka America Pharmaceutical, Inc.
Contracted research: Janssen

The writer (Katherine Kahn), activity planners (Rachel Karcher and Lisa Rinehart), and other employees of Med-IQ and the College of Physicians and Surgeons have no financial relationships to disclose.

Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of CME. As an ACCME-accredited provider of CME, it is the policy of The College of Physicians and Surgeons to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. The College of Physicians and Surgeons is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.

The College of Physicians and Surgeons and Med-IQ are not liable for any decision made or action taken in reliance upon the information provided through this activity.

The information provided through this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

ADA Statement
Med-IQ fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact the Director of CME at 443 543 5200.

Hardware/Software Requirements
Operating System
Microsoft Windows® 2000, XP, Vista
Mac OS 10.1, 10.2, 10.3, 10.4

Microsoft Internet Explorer 5.5 or later
Firefox 1.5
Netscape 7 or later

PDF Viewer
Adobe Acrobat Reader® or Adobe Reader
Download the latest version at http://www.adobe.com/products/acrobat/readstep2.html

Connection Type
High bandwidth (300k) is strongly recommended
Low bandwidth (100k) results in less than optimal quality
Dial-up/modem is not recommended

Acknowledgment of Commercial Support
This activity is supported by an educational grant from Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC.

In Cooperation With
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education by The College of Physicians and Surgeons and Med-IQ. The College of Physicians and Surgeons is accredited by the ACCME to provide continuing medical education for physicians.

© 2011 Med-IQ® and Columbia University. All rights reserved.

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or email info@med-iq.com. For technical assistance, please refer to our support manual.